基于WEO分类系统分析结肠镜检查后结直肠癌的原因
该研究回顾性分析英格兰单中心2010至2017年107例结肠镜检查后结直肠癌(PCCRC),采用世界内镜组织(WEO)分类系统进行根因分析。结果显示43%发生于高危患者,73%受内镜技术因素影响,89%被认为可避免;若半数可避免PCCRC被预防,PCCRC-3y的2%基准率可实现。
要点
- 43%的PCCRC发生于高危患者,需更 vigilant 监测。
- 73%的PCCRC受内镜技术因素影响,27%受决策因素影响。
- 89%的PCCRC被认为可避免,预防半数可使PCCRC-3y达2%基准。
核心结论
- 43%的PCCRC发生于高危患者,可能通过更 vigilant 的监测减少。
- 73%的PCCRC受内镜技术因素影响,17%受行政因素影响,27%受决策因素影响。
- 89%的PCCRC被认为可避免;若半数可避免PCCRC被预防,PCCRC-3y的2%基准率可实现。
研究设计与样本
- 使用编码和内镜数据,回顾临床、病理、放射和内镜发现,按WEO建议进行根因分析。
主要发现
- 43%的PCCRC位于高危患者(炎症性肠病、既往结直肠癌、既往多发大息肉或遗传性癌症综合征)。
- 66%的PCCRC位于肝曲远端。
- 结肠镜检查后结直肠肿瘤大小与诊断时间无相关性。
- 19%的指数结肠镜检查肠道准备差,仅36%的完整结肠镜检查有充分的完成光文档记录。
- 27%分类为可能漏诊病变且前次检查充分,58%为可能漏诊病变且前次检查不充分,8%为检出病变未切除,7%为既往观察病变不完全切除。
关键数值与推荐
- WEO分类:可能漏诊病变(前次检查充分/不充分)、检出病变未切除、可能不完全切除既往病变。
- PCCRC-3y指指数结肠镜检查后6至36个月诊断的癌症,基准率为2%。
临床怎么用
- 采用WEO系统对PCCRC进行根因分析,识别技术、决策和行政因素。
- 加强高危患者监测,改善肠道准备和光文档记录,减少可避免PCCRC。
局限性
- 单中心回顾性分析,样本量107例,结果外推需谨慎。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Postcolonoscopy colorectal cancer (PCCRC) is CRC diagnosed after a colonoscopy in which no cancer was found. A consensus article from the World Endoscopy Organization (WEO) proposed an approach for investigating and categorizing PCCRCs detected within 4 years of a colonoscopy. We aimed to identify cases of PCCRC and the factors that cause them, test the WEO system of categorization, quantify the proportion of avoidable PCCRCs, and propose a target rate for PCCRCs detected within 3 years of a colonoscopy that did not detect CRC. METHODS: We performed a retrospective analysis of 107 PCCRCs identified at a single medical center in England from January 1, 2010, through December 31, 2017 using coding and endoscopy data. For each case, we reviewed clinical, pathology, radiology, and endoscopy findings. Using the WEO recommendations, we performed a root-cause analysis of each case, categorizing lesions as follows: possible missed lesion, prior examination adequate; possible missed lesion, prior examination inadequate; detected lesion, not resected; or likely incomplete resection of previously identified lesion. We determined whether PCCRCs could be attributed to the colonoscopist for technical or decision-making reasons, and whether the PCCRC was avoidable or unavoidable, based on the WEO categorization and size of tumor. The endoscopy reporting system provided performance data for individual endoscopists. RESULTS: Of the PCCRCs identified, 43% were in high-risk patients (those with inflammatory bowel disease, previous CRC, previous multiple large polyps, or hereditary cancer syndromes) and 66% were located distal to the hepatic flexure. There was no correlation between postcolonoscopy colorectal tumor size and time to diagnosis after index colonoscopy. Bowel preparation was poor in 19% of index colonoscopies, and only 36% of complete colonoscopies had adequate photodocumentation of completion. Development of 73% of PCCRCs was determined to be affected by technical endoscopic factors, 17% of PCCRCs by administrative factors (follow-up procedures delayed/not booked by administrative staff), and 27% of PCCRCs by decision-making factors. Twenty-seven percent of PCCRCs were categorized as possible missed lesion, prior examination adequate; 58% as possible missed lesion, prior examination inadequate; 8% as detected lesion, not resected; and 7% as incomplete resection of previously observed lesion; 89% were deemed to be avoidable. CONCLUSIONS: In a retrospective analysis of PCCRCs, using the WEO system of categorization, we found 43% to occur in high-risk patients; this might be reduced with more vigilant surveillance. Measures are needed to reduce technical, decision-making, and administrative factors. We found that 89% of PCCRCs may be avoidable. If half of avoidable PCCRCs could be prevented, the target rate of 2% for the PCCRC-3y (cancer diagnosed between 6 and 36 months after index colonoscopy) benchmark would be achievable.
引用
- Anderson R, Burr NE, Valori R, et al. Causes of Post-Colonoscopy Colorectal Cancers Based on World Endoscopy Organization System of Analysis. Gastroenterology. 2020. PMID: 31926170. doi:10.1053/j.gastro.2019.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。